BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18491315)

  • 1. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model.
    Tong A; Wu L; Lin Q; Lau QC; Zhao X; Li J; Chen P; Chen L; Tang H; Huang C; Wei YQ
    Proteomics; 2008 May; 8(10):2012-23. PubMed ID: 18491315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15.
    Yao Y; Li J; Lu Z; Tong A; Wang W; Su X; Zhou Y; Mu B; Zhou S; Li X; Chen L; Gou L; Song H; Yang J; Wei Y
    Electrophoresis; 2011 Aug; 32(15):2004-12. PubMed ID: 21739463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2.
    Huang Q; Wang L; Bai S; Lin W; Chen W; Lin J; Lin X
    J Med Virol; 2009 Sep; 81(9):1539-50. PubMed ID: 19626621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
    Zhang J; Niu D; Sui J; Ching CB; Chen WN
    Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein.
    Tong A; Gou L; Lau QC; Chen B; Zhao X; Li J; Tang H; Chen L; Tang M; Huang C; Wei YQ
    J Proteome Res; 2009 Feb; 8(2):1037-46. PubMed ID: 19117405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
    Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
    Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2.
    Wang J; Jiang D; Zhang H; Lv S; Rao H; Fei R; Wei L
    Proteomics; 2009 Mar; 9(6):1672-82. PubMed ID: 19242931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.
    Xie HY; Xia WL; Zhang CC; Wu LM; Ji HF; Cheng Y; Zheng SS
    Acta Pharmacol Sin; 2007 Jul; 28(7):975-84. PubMed ID: 17588333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening proteins related to retinoic acid resistance by proteomic analysis].
    Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
    Vester D; Rapp E; Gade D; Genzel Y; Reichl U
    Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon.
    Fang C; Yi Z; Liu F; Lan S; Wang J; Lu H; Yang P; Yuan Z
    Proteomics; 2006 Jan; 6(2):519-27. PubMed ID: 16317778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
    Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus.
    Kuramitsu Y; Harada T; Takashima M; Yokoyama Y; Hidaka I; Iizuka N; Toda T; Fujimoto M; Zhang X; Sakaida I; Okita K; Oka M; Nakamura K
    Electrophoresis; 2006 Apr; 27(8):1651-8. PubMed ID: 16609938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iTRAQ-coupled 2-D LC-MS/MS analysis of protein profile associated with HBV-modulated DNA methylation.
    Niu D; Sui J; Zhang J; Feng H; Chen WN
    Proteomics; 2009 Aug; 9(15):3856-68. PubMed ID: 19639599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis].
    Feng JT; Liu YK; Dai Z; Zhou HJ; Song HY; Qin LX; Jin H; Lu HJ; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):832-5. PubMed ID: 16313728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene expression profiles and proteomics analysis of the cell transfected with the mutant type of COOH-terminal deleted of hepatitis B virus X].
    Liu XH; Chen Y; Wang L; Zhao HH; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3425-9. PubMed ID: 16409865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.